DUBLIN, Jun 15, 2011 (BUSINESS WIRE) --
Covidien (NYSE: COV), a leading global provider of healthcare products,
today announced several leadership changes that will streamline its
organization to accelerate growth and innovation. These changes are all
effective July 1, 2011.
Bryan C. Hanson will become Group President, with responsibility for the
Surgical Devices and Energy-based Devices businesses. Bryan joined
Covidien in 1992 and has held several positions of increasing
responsibility, including his current position, President, Energy-based
Devices. During the five years Bryan led this business, energy sales
doubled and a number of innovative new products were successfully
Peter L. Wehrly will become Group President, with responsibility for the
Respiratory & Monitoring Solutions and Vascular Therapies businesses, as
well as regional responsibility for Japan, Australia-New Zealand and
Canada. Pete joined Covidien in 2009 as President, Respiratory &
Monitoring Solutions, and has more than 20 years of experience in the
medical devices industry.
Michael Sgrignari will become Senior Vice President, Quality and
Operations, with global responsibility for Quality Assurance, Regulatory
Affairs, Logistics, Environmental Health & Safety and Operational
Excellence. Mike joined Covidien in 1991 and has held a number of
increasingly responsible positions in manufacturing and operations
during his tenure.
Bryan, Pete and Mike will all report to José (Joe) E. Almeida, currently
President, Medical Devices and CEO-elect. The position of President,
Medical Devices, will be eliminated, but Medical Devices will remain an
external reporting segment.
James M. Muse, Senior Vice President, Global Supply Chain, will retire
after 32 years of outstanding service. Scott Flora, President, Surgical
Devices, who successfully led the business for the past five years, will
leave Covidien to pursue other career opportunities.
"These appointments will enhance our ability to deliver strong,
sustained and profitable growth as we execute against our strategic
initiatives," said Almeida. "I'd like to thank Jim and Scott for their
years of service to Covidien and wish them the best in their future
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2010 revenue of $10.4 billion, Covidien has 41,000
employees worldwide in more than 65 countries, and its products are sold
in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Bruce Farmer, 508-452-4372
Coleman Lannum, CFA, 508-452-4343
Todd Carpenter, 508-452-4363